Annual Drug Patent Expirations for ENTEREG
Entereg is a drug marketed by Cubist Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ENTEREG.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in ENTEREG is alvimopan. One supplier is listed for this compound. Additional details are available on the alvimopan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
